What Is the Dark Side of Semaglutide?
US$ 21.23
do glp 1 agonists cause pancreatic cancer GLP-1 and Pancreatitis Risk Do Weight Loss Injections Cause
Description
doi: 10.1111/dom.15058 [DOI] [PubMed] [Google Scholar] 46
doi: 10.3389/fendo.2018.00402
aHR, adjusted hazard ratio
GLP-1 receptor agonists have shown great success in supporting weight loss and controlling appetite
Other GLP-1R agonists have demonstrated extensive pleiotropic effects, including benefits in managing comorbidities such as osteoarthritis, cardiovascular disease, and neurodegenerative disorders
however, it is well-established that GLP-1 receptors (which semaglutide stimulates) are involved in the regulation of stomach emptying and motility
